CBNGO00040—Key tool for glycoprotein synthesis and glycobiology research 1449039-94-4

Glycan Oxazoline is a class of structurally unique sugar derivatives that play a crucial role in the fields of chemical biology and glycoprotein engineering. As an efficient and highly selective glycosylation donor, it has become a revolutionary tool to achieve the precise construction of complex sugar chains, especially the homogeneous synthesis of glycoproteins.

Chemical Information

Chemical name: CBNGO00040 (glycosyl oxazoline derivative)

Common name: Glycosyloxazoline

Chemical formula: C₂₆H₄₁F₂NO₁₈

Molecular weight: 693.60 g/mol

CAS number: 1449039-94-4

Category: Glycan Oxazoline

Structural features

The core feature of glycosyl oxazoline is the 1,2-oxazoline ring structure at the end of its molecule, which is formed by the cyclization of C1 of the glycosyl and the adjacent C2 position through oxygen atoms and nitrogen atoms.

High-energy glycosylation donor: The oxazoline ring has a certain tension, making it an activated glycosyl donor under enzymatic conditions, which can be efficiently recognized and utilized by specific glycoside hydrolases (such as endoglycosidase ENGase) or glycosyltransferases.

Stereoselective retention: In enzymatic reactions, the glycosylation process of glycosyloxazolines is usually carried out in a stereoconfiguration-preserving manner, that is, the anomeric carbon configuration of the donor sugar is perfectly maintained in the product, which is crucial for the synthesis of natural sugar chains with precise stereostructure.

Excellent stability and reaction controllability: Compared with other activated glycosyl donors (such as glycosyl fluorides), oxazoline derivatives are more stable under conventional conditions and are easier to store and operate. The reaction is mainly carried out under enzyme catalysis, with mild conditions, few side reactions, and excellent chemical and regional selectivity.

Main applications and advantages

The core building blocks of homogeneous synthesis and remodeling of glycoproteins

The key to chemoenzymatic glycoprotein synthesis: glycosyloxazoline is the core substrate in the "glycoside rearrangement" reaction. Endoglycosidase can efficiently and specifically transfer its glycosyl group to a specific glycosylation site (usually asparagine-linked GlcNAc) on a protein or peptide chain, thereby achieving the synthesis of a complete, structurally uniform N-linked glycoprotein or glycopeptide. This technology provides a standardized path to obtain structurally well-defined glycoprotein drugs and probes.

Sugar chain engineering and transformation: By synthesizing glycosyl oxazolines with different structures, researchers can accurately introduce specific oligosaccharide chains onto target proteins to study the relationship between sugar chain structure and function, or to customize glycoprotein therapeutics with optimized pharmacodynamic properties.

Enzyme mechanism research and glycobiology tool development

Ideal substrate for glycoside hydrolase/transferase studies: Glycosyloxazolines are classic probe molecules for studying the catalytic mechanism of retained glycosidases (especially the double displacement mechanism through the formation of covalent glycosyl-enzyme intermediates). Its structure and reactivity provide key information for elucidating the structure of the enzyme's active center and the role of catalytic residues.

Cell surface glycolabeling and imaging: With appropriate design (such as the introduction of reporter groups), glycosyloxazolines can be used to develop new bioorthogonal labeling strategies to achieve labeling and tracking of specific glycoproteins or glycan structures at the living cell level, facilitating glycomic research and the discovery of disease-related glycobiomarkers.

Potential platform for novel glycoconjugate vaccine and drug development

Vaccine design based on carbohydrate antigens: Certain bacterial capsular polysaccharides or oxazoline derivatives of tumor-associated carbohydrate antigens can be used as antigen mimics and coupled with carrier proteins through enzymatic methods to construct polysaccharide-protein conjugate vaccines with clear structures and stronger immunogenicity.

Precursor of stable sugar mimetics: Its special ring structure can be used as a source of inspiration or synthetic precursor for designing glycosidase inhibitors or glycosyltransferase inhibitors, providing new candidate molecular skeletons for the development of antiviral, antibacterial or antitumor drugs.

Conclusion

Glycosyloxazoline is much more than a chemical intermediate, it is a bridge molecule connecting glycochemistry and glycoprotein biology. Its unique activation mechanism and excellent enzyme substrate specificity provide a powerful tool for understanding and controlling the complex glycosylation process in living systems with atomic precision. From the in-depth exploration of basic glycobiological mechanisms, to the rational design and production of uniform glycoprotein drugs, to the development of next-generation glycoconjugate vaccines, glycosyloxazoline technology is continuing to promote the progress of related cutting-edge scientific fields and translational medicine, showing broad application prospects.

The above information is provided by the editor of KASONS and is for scientific research only.